There are few large-cap miners whose shares are as geared to commodity prices as India's Vedanta Resources. Last year's share price performance — a rise of 327 per cent — said as much. So, too, did yesterday's third-quarter update. The imminent redemption of a $725 million convertible bond at a 40 per cent discount to the current share price may cause short-term volatility. Even so, at £24.84, or ten times next year's earnings, hold on, says the Times.

While Tullow trades on a huge multiple (162.1 times Evolution's forecast full-year earnings) that's only because the company just keeps delivering. The Independent said buy twice last year, and Tullow has rewarded us handsomely. There's enough here to suggest this tiger can be ridden higher still. Keep buying.

Nobody in the pub sector will nail their flag to the mast and call the end of the downturn, least of all Rooney Anand, the highly cautious chief executive of Greene King. But yesterday's trading update covering the 38-week period to January 24 suggests that the Suffolk brewer and pub operator is as close as any of its peers to getting back on an even keel. The shares, up 9¼p at 442½p, a multiple of about ten times full-year earnings, are well worth holding, according to the Times.

News from biotechnology group Plant Health Care yesterday was not great, but it's not a disaster either. The company is still loss making and it is not paying a dividend. However, prospects for its yield-increasing agricultural products are very exciting. The shares, which are down 15pc from their recommendation on August 18, remain a speculative buy, says the Telegraph.

There are few bigger in the speciality chemicals sector than Johnson Matthey and size matters in this sector. The Independent says just hold for the moment. Buy on any signs of weakness in the shares.

It did not take one of Renishaw's precision measuring devices to gauge the turnaround in yesterday's first-half numbers. At 605p, or 21 times next year's earnings, the shares look stretched — but not once the likelihood of further upgrades is factored in. Buy on weakness, says the Times.

Charles Stanley's shares are rather illiquid, but at 11.9 times forecast full-year earnings with a prospective yield of 3.7 per cent, they trade at a discount to the sector. Prospects look good, so the Independent says buy.


Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.

Related share prices
Greene King (GNK) share price
Johnson Matthey (JMAT) share price
Charles Stanley Group (CAY) share price
Lonrho (LONR) share price
Renishaw (RSW) share price
Tullow Oil (TLW) share price
Vedanta Resources (VED) share price
Plant Health Care (PHC) share price
Playtech Ltd. (PTEC) share price